23 May 2013
Keywords: wyeth, raises, fy2005, earnings, guidance, drug, major
Article | 04 July 2005
US drug major Wyeth is raising its 2005 full-year guidance to $2.80-$2.90 diluted earnings per share. The company noted that high ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.